Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Information Needs and Perspectives on a Patient Decision Aid for Biologic Therapy: A Qualitative Interview Study Among Individuals with Rheumatoid Arthritis.

Patient preference and adherence·2026
Same author

Development and initial validation of a brief measure of uncertainty in rheumatic disease.

Journal of health psychology·2026
Same author

Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies.

Diabetes care·2026
Same author

A novel cohort to assess longitudinal glucocorticoid toxicity in individuals with rheumatic diseases: objectives, design, and initial baseline characteristics of the LONG-TOX cohort.

Seminars in arthritis and rheumatism·2025
Same author

Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16.

Dermatology and therapy·2025
Same author

Longitudinal Changes in Serum Urate Levels From Premenopause Through Postmenopause: Interrupted Time-Series Analyses.

Arthritis & rheumatology (Hoboken, N.J.)·2025

Related Experiment Video

Updated: Jul 8, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Psoriatic arthritis epidemiology.

Arathi R Setty1, Hyon K Choi

  • 1Division of Rheumatology, Department of Medicine, University of British Columbia, Arthritis Research Centre of Canada, 895 West 10th Avenue, Vancouver, BC V5Z 1L7, Canada.

Current Rheumatology Reports
|January 8, 2008
PubMed
Summary
This summary is machine-generated.

Psoriatic arthritis (PsA) epidemiology shows varied prevalence due to genetics and environment. More research is needed on risk factors and mortality impact for this rare condition.

More Related Videos

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
06:06

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

Published on: July 22, 2021

Related Experiment Videos

Last Updated: Jul 8, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
06:06

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

Published on: July 22, 2021

Area of Science:

  • Rheumatology
  • Epidemiology
  • Immunology

Background:

  • Psoriatic arthritis (PsA) epidemiology data is limited due to a lack of standard case definitions and its rarity.
  • Existing prevalence estimates for PsA vary significantly more than incidence estimates.
  • Understanding PsA epidemiology is crucial for patient care and research.

Purpose of the Study:

  • To review and summarize recent findings on the epidemiology of psoriatic arthritis (PsA).
  • To highlight variations in prevalence and incidence estimates and their potential causes.
  • To discuss the current understanding of risk factors, quality of life, and mortality associated with PsA.

Main Methods:

  • Systematic review of recent epidemiological studies on psoriatic arthritis (PsA).
  • Analysis of reported prevalence and incidence data across diverse populations.
  • Evaluation of studies investigating risk factors, quality of life, and mortality in PsA patients.

Main Results:

  • Prevalence estimates for PsA show considerable variation, influenced by genetic and environmental factors, as well as study methodologies.
  • Incidence estimates for PsA appear more consistent than prevalence estimates.
  • Quality of life in PsA is comparable to rheumatoid arthritis, but PsA's impact on mortality remains inconclusive.

Conclusions:

  • Recent studies offer insights into PsA epidemiology, but data gaps persist, particularly regarding risk factors and mortality.
  • Standardized case definitions are needed to improve the accuracy and comparability of PsA epidemiological research.
  • Further investigation into the long-term outcomes, including mortality, is essential for a comprehensive understanding of psoriatic arthritis.